We are live on ! Find out more
JNJ icon

Johnson & Johnson

2,121 hedge funds and large institutions have $206B invested in Johnson & Johnson in 2014 Q4 according to their latest regulatory filings, with 206 funds opening new positions, 782 increasing their positions, 910 reducing their positions, and 51 closing their positions.

New
Increased
Maintained
Reduced
Closed

304% more first-time investments, than exits

New positions opened: 206 | Existing positions closed: 51

7% more funds holding

Funds holding: 1,9882,121 (+133)

4% more capital invested

Capital invested by funds: $199B → $206B (+$7.19B)

0.1% less ownership

Funds ownership: 66.11%66.01% (-0.1%)

8% less funds holding in top 10

Funds holding in top 10: 720659 (-61)

14% less repeat investments, than reductions

Existing positions increased: 782 | Existing positions reduced: 910

34% less call options, than puts

Call options by funds: $1.66B | Put options by funds: $2.52B

Holders
2,121
Holders Change
+133
Holders Change %
+6.69%
% of All Funds
56.54%
Holding in Top 10
659
Holding in Top 10 Change
-61
Holding in Top 10 Change %
-8.47%
% of All Funds
17.57%
New
206
Increased
782
Reduced
910
Closed
51
Calls
$1.66B
Puts
$2.52B
Net Calls
-$858M
Net Calls Change
-$373M
Name Holding Trade Value Shares
Change
Change in
Stake
ST
976
Smithfield Trust
Pennsylvania
$5.67M -$686K -6,506 -11%
NCM
977
Novare Capital Management
North Carolina
$5.67M +$140K +1,326 +3%
FCMC
978
Founders Capital Management (Connecticut)
Connecticut
$5.65M +$119K +1,126 +2%
CWM
979
Calamos Wealth Management
Illinois
$5.65M -$76K -721 -1%
ATC
980
Argent Trust Company
Louisiana
$5.64M -$324K -3,079 -5%
CS
981
Cannell & Spears
New York
$5.64M
SFSG
982
Stearns Financial Services Group
North Carolina
$5.63M +$5.06K +48 +0.1%
Two Sigma Advisers
983
Two Sigma Advisers
New York
$5.6M -$21M -199,223 -79%
TCM
984
Tran Capital Management
California
$5.58M -$505K -4,795 -8%
OC
985
Oppenheimer & Close
New York
$5.56M -$31.6K -300 -0.6%
RJA
986
Robshaw & Julian Associates
New York
$5.56M +$52.7K +500 +0.9%
WA
987
Whitebox Advisors
Minnesota
$5.56M +$56.7K +538 +1%
BIM
988
Bridges Investment Management
Nebraska
$5.55M +$531K +5,040 +10%
Aristotle Capital Management
989
Aristotle Capital Management
California
$5.55M +$15.8K +150 +0.3%
HAM
990
Highstreet Asset Management
Ontario, Canada
$5.55M +$82.4K +782 +1%
JWBC
991
J.W. Burns & Co
New York
$5.55M -$108K -1,027 -2%
DPIM
992
Duff & Phelps Investment Management
Illinois
$5.54M -$360K -3,420 -6%
PWAP
993
Private Wealth Advisors (Pennsylvania)
Pennsylvania
$5.53M +$12.8K +121 +0.2%
DG
994
Davidson & Garrard
Virginia
$5.52M -$27.8K -264 -0.5%
WTB
995
Washington Trust Bank
Washington
$5.51M +$56.1K +532 +1%
FA
996
FDx Advisors
Illinois
$5.46M -$1.27M -12,066 -19%
CAM
997
Cubic Asset Management
Massachusetts
$5.45M -$36.9K -350 -0.7%
ICOA
998
Investment Centers of America
North Dakota
$5.45M -$766K -7,266 -12%
SHGA
999
Sand Hill Global Advisors
California
$5.43M -$305K -2,897 -5%
LW
1000
Linscomb Wealth
Texas
$5.43M -$262K -2,483 -5%

JNJ Hedge Fund Activity: Q4 2014 in Review

2,121 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q4 2014, worth a combined $206B — up 3.6% from $199B a quarter earlier.

Buyers outnumbered sellers: 206 funds opened new JNJ positions and 51 closed out — a net gain of 155 holders — while 782 added to existing stakes and 910 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $920M. The largest seller was T. Rowe Price Associates, cutting an estimated $652M.

  • 2,121 institutional investors held Johnson & Johnson (JNJ) as of Q4 2014, up from 1,988 in Q3 2014.
  • Funds reported $206B of Johnson & Johnson stock for Q4 2014, up 3.6% quarter-over-quarter.
  • 206 funds opened new Johnson & Johnson positions in Q4 2014 and 51 closed out, a net change of +155 holders.
  • The largest Johnson & Johnson buyer in Q4 2014 was Fidelity Investments, an estimated $920M added.
  • The largest Johnson & Johnson seller in Q4 2014 was T. Rowe Price Associates, an estimated $652M sold.

Based on aggregated 13F filings for Q4 2014.